Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment.

BACKGROUND AIMS Because of the inflammatory nature and extensive stromal compartment in pancreatic tumors, we investigated the role of mesenchymal stromal cells (MSC) to engraft selectively in pancreatic carcinomas and serve as anti-tumor drug delivery vehicles to control pancreatic cancer progression. METHODS Human pancreatic carcinoma cells, PANC-1, expressing renilla luciferase were orthotopically implanted into SCID mice and allowed to develop for 10 days. Firefly luciferase-transduced MSC or MSC expressing interferon (IFN)-beta were then injected intraperitoneally weekly for 3 weeks. Mice were monitored by bioluminescent imaging for expression of renilla (PANC-1) and firefly (MSC) luciferase. RESULTS MSC selectively homed to sites of primary and metastatic pancreatic tumors and inhibited tumor growth (P=0.032). The production of IFN-beta within the tumor site by MSC-IFN-beta further suppressed tumor growth (P=0.0000083). Prior studies indicated that MSC home to sites of inflammation; therefore, we sought to alter the tumor microenvironment through treatment with a potent anti-inflammatory agent. After treatment, inflammation-associated mediators were effectively down-regulated, including NFkappaB, vascular endothelial growth factor (VEGF) and interleukin (IL)-6 as well as chemokines involved in MSC migration (CCL3 and CCL25). Treatment with the anti-inflammatory agent CDDO-Me before and after MSC-IFN-beta injections resulted in reduction of MSC in the tumors and reversed the positive effect of tumor inhibition by MSC-IFN-beta alone (P=0.041). CONCLUSIONS These results suggest that MSC exhibit innate anti-tumor effects against PANC-1 cells and can serve as delivery vehicles for IFN-beta for the treatment of pancreatic cancer. However, these beneficial effects may be lost in therapies combining MSC with anti-inflammatory agents.

[1]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[2]  L. Buscail,et al.  Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo , 2009, PloS one.

[3]  C. Kaps,et al.  Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. , 2009, Experimental cell research.

[4]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[5]  M. Weiss,et al.  Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. , 2009, Cancer research.

[6]  Jun Ren,et al.  [Inoculation of murine bone marrow mesenchymal stem cells induces tumor necrosis in mouse with orthotopic hepatocellular carcinoma]. , 2008, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[7]  H. Friess,et al.  VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma , 2008, British Journal of Cancer.

[8]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[9]  M. Andreeff,et al.  Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells , 2008, Gene Therapy.

[10]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[11]  M. Andreeff,et al.  The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. , 2008, Cytotherapy.

[12]  W. Woodward,et al.  Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. , 2007, Cancer research.

[13]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[14]  Gerald C. Chu,et al.  Stromal biology of pancreatic cancer , 2007, Journal of cellular biochemistry.

[15]  M. Andreeff,et al.  Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles , 2007, International journal of hematology.

[16]  John Calvin Reed,et al.  Triterpenoids Display Single Agent Anti-tumor Activity in a Transgenic Mouse Model of Chronic Lymphocytic Leukemia and Small B Cell Lymphoma , 2007, PloS one.

[17]  M. Konopleva,et al.  Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies , 2007 .

[18]  M. Konopleva,et al.  The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. , 2007, Cancer research.

[19]  F. Djouad,et al.  Earlier Onset of Syngeneic Tumors in the Presence of Mesenchymal Stem Cells , 2006, Transplantation.

[20]  Xiaobing Fu,et al.  Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages , 2006, Cell and Tissue Research.

[21]  Yongchang Chen,et al.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. , 2006, Experimental and molecular pathology.

[22]  A. Straube,et al.  Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC) , 2006, Experimental Neurology.

[23]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[24]  Nalini Singh,et al.  Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model , 2006, The journal of gene medicine.

[25]  M. Konopleva,et al.  Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells , 2006, Molecular Cancer Therapeutics.

[26]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[27]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[28]  I. Weissman,et al.  Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis. , 2005, Stem cells and development.

[29]  M. Sporn,et al.  2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer* , 2005, Journal of Biological Chemistry.

[30]  Simon C Watkins,et al.  Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors , 2005, Cancer Gene Therapy.

[31]  Jie Hao,et al.  Antileukemic effect of interleukin-7-transduced bone marrow stromal cells in mice following allogeneic T-cell-depleted bone marrow transplantation. , 2005, Transplantation proceedings.

[32]  M. Sporn,et al.  The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. , 2005, Cancer research.

[33]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[34]  T. Hunt,et al.  Bone Marrow Contribution to Tumor-Associated Myofibroblasts and Fibroblasts , 2004, Cancer Research.

[35]  M. Andreeff,et al.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. , 2004, Journal of the National Cancer Institute.

[36]  M. Sporn,et al.  The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia , 2004, Cancer Research.

[37]  Robert Jaster,et al.  Molecular regulation of pancreatic stellate cell function , 2004, Molecular Cancer.

[38]  H. Tsuda,et al.  Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.

[39]  M. Lindvall,et al.  Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. , 2003, Experimental and molecular pathology.

[40]  M. Sporn,et al.  The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  L. Naldini,et al.  Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells , 2003, Nature Medicine.

[42]  V. Starnes,et al.  Migration of mesenchymal stem cells to heart allografts during chronic rejection , 2003, Transplantation.

[43]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[44]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[45]  M. Chopp,et al.  MCP-1, MIP-1, IL-8 and Ischemic Cerebral Tissue Enhance Human Bone Marrow Stromal Cell Migration in Interface Culture , 2002, Hematology.

[46]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[47]  M. Chopp,et al.  Intrastriatal Transplantation of Bone Marrow Nonhematopoietic Cells Improves Functional Recovery After Stroke in Adult Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  G. Maestroni,et al.  Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice , 1999, Cellular and Molecular Life Sciences CMLS.

[49]  M. Sporn,et al.  A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. , 1999, Cancer research.

[50]  M. Sporn,et al.  Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. , 1998, Bioorganic & medicinal chemistry letters.

[51]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[52]  P. Guillou,et al.  Biology of pancreatic cancer. , 1991, Gut.

[53]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.